Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (8,067,455) $ (4,116,876)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 349,965 537,522
Consulting expense for restricted shares issued 11,500 164,070
Change in fair value of warrant liability 4,181,298 (20,942)
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 67,091 153,775
Australia research and development incentives receivable (18,602) (51,243)
Other receivables (71,856)  
Accounts payable 237,018 (35,163)
Accrued expenses (275,759) 8,208
Net cash used in operating activities (3,586,800) (3,360,649)
Cash flows from financing activities:    
Proceeds from At-The-Market offering 745,251  
Payment of offering transactions costs (276,889)  
Net cash provided by financing activities 4,717,048  
Net effect of foreign currency exchange on cash (9,494) (3,966)
Net increase (decrease) in cash 1,120,754 (3,364,615)
Cash at beginning of period 7,150,695 10,950,927
Cash at end of period 8,271,449 $ 7,586,312
Supplemental disclosure of cash flow information:    
Warrants issued in connection with private placement offering 1 2,049,600  
Warrants issued in connection with private placement offering 2 1,190,111  
Private Placement Offering 1    
Cash flows from financing activities:    
Proceeds from sale of common stock 2,920,696  
Private Placement Offering 2    
Cash flows from financing activities:    
Proceeds from sale of common stock $ 1,327,990